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there were issues requiring discussion in 46% of patients.
Commonly cited issues were related to holidays, sex life,
tiredness, mobility, and depression. These issues were ei-
ther discussed with the nurse immediately in person
(65%), or the patient was contacted by telephone (28%)
or post (7%). Of those patients who were contacted,
70% were interested in discussing the issues, of whom 3
were referred to andrology clinics and 11 were to be re-
viewed at a future appointment. CONCLUSION: Mea-
surement of QoL is feasible and useful in the routine clin-
ical nursing practice.
PRN5
QUALITY OF LIFE AND HEALTH CARE 
RESOURCE UTILIZATION IN OVERACTIVE 
BLADDER PATIENTS WITH 
URGE INCONTINENCE
Rosner AJ1, Becker DL1, Borrie MJ2, Hobbs C3, Fedorkow 
DM3, Vallely JF2, King HJ2, Turpie I3
1Innovus Research Inc., Burlington, ON, Canada; 2University of 
Western Ontario, London, ON, Canada; 3McMaster University, 
Hamilton, ON, Canada
Urge incontinence (UI) significantly affects the physical,
psychological, and economic aspects of the lives of af-
fected individuals. OBJECTIVE: This study assessed the
impact of UI on patients’ health-related quality of life
(HR-QoL) and resource utilization. METHODS: A ques-
tionnaire, administered to ambulatory out-patients diag-
nosed with UI, collected demographic information, mic-
turition and leakage data, HR-QoL and resource use
estimates. HR-QoL was measured using the EuroQoL
(EQ-5D) and King’s Health Questionnaire (KHQ). The
KHQ is a disease-specific instrument which explores
eight domains (health perceptions, incontinence impact,
role, physical and social limitations, personal relation-
ships, emotions, sleep/energy). RESULTS: Patients (n 
60) were 62.5  15.5 years old and 95% female. During
a typical 24-hour period, patients experienced a median
of 3 leakages and a mean of 13 micturitions, 3 of which
occurred nocturnally. Eighty-three percent of patients felt
their condition interfered with their usual activities. The
average utility value determined using the EQ-5D was
0.68. Of the domains of the KHQ, patients indicated the
greatest impairment in the incontinence impact domain.
Other domains considerably affected were sleep/energy
and role and physical limitations. Patients had 102 visits
with healthcare providers and 68 tests/procedures in the
4 weeks preceding the study. Feminine hygiene products,
incontinence pads and diapers were used by 43%, 32%
and 8% of patients at a median of 16, 12 and 7 units per
week, respectively. CONCLUSIONS: UI is a major ob-
stacle to patients’ quality of life, specifically impeding
their sleep and energy level, in addition to causing role
and physical impairments. UI also has considerable impact
on resource utilization.
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There are three limitations in the application of current
HRQL questionnaires related to overactive bladder (OAB):
1) no OAB-specific questionnaire has been developed in
an OAB population with patients experiencing OAB
symptoms but not incontinence; 2) the sample popula-
tions on which such questionnaires have been tested have
been restricted to primarily clinical patients with inconti-
nence; 3) past questionnaires have been developed in fe-
male-only populations. OBJECTIVE: To initiate the de-
velopment of an OAB-specific HRQL questionnaire.
METHODS: Participants were recruited via newspaper
advertisement and screened to ensure they met the study
criteria (predominantly OAB-dry). The groups were gen-
der-specific: Group 1  7 men; Group 2  9 women.
The participants were asked open-ended questions on
symptoms (frequency, urgency and leakage), coping be-
haviors and life impact. Data were analyzed using con-
tent analysis. A draft questionnaire was developed and
reviewed by 88% (14) of the focus group participants
who indicated that the questionnaire captured their
thoughts and experiences. RESULTS: Participants re-
ported significant impact in their HRQL due to OAB in a
variety of domains. The symptoms of frequency, urgency,
and nocturia caused significant alterations in productiv-
ity, travel/commuting, sleep, physical activities, social
functioning, relationships, and psychological well-being,
as well as causing a number of coping behaviors. Most is-
sues were similar between men and women. Men re-
ported interrupted sleep as the greatest area of HRQL
impact; women were unable to identify a single promi-
nent issue or domain. CONCLUSION: This instrument
reflects numerous concerns and issues identified by OAB
focus group participants that were not found in previ-
ously developed questionnaires. It is currently in the vali-
dation phase for future research.
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OBJECTIVE: Overactive bladder (OAB) is a highly prev-
alent condition that can result in substantial changes to
an individual’s daily activities. Behavioral changes to
cope with OAB symptoms are likely to occur early in the
natural history of OAB. In later stages, OAB tends to
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more directly affect activities. As one step in developing
an OAB-specific QoL instrument, we conducted a popu-
lation-based study to determine the reliability of report-
ing of coping strategies and other aspects of QoL thought
to be OAB-related. METHODS: A US population sample
of 231 adults completed an interview twice, on average,
two weeks apart. Detailed questions were asked about
OAB symptoms, coping strategies, and the psychological/
physical impact of symptoms in the past 4 weeks. RE-
SULTS: The most common coping strategies were re-
stricting fluid intake (day or night) and defensive voiding.
Relatively high kappas (i.e., 0.60) were observed for
‘concerned about drinking more fluid’, ‘limiting travel’,
‘defensive voiding in a new place’, and ‘drink less fluid at
night’. Reports on the level of distress caused by cop-
ing and on the use of protective pads were highly reliable
(r  0.81; r  0.82). The most common terms for report-
ing feelings about bladder control included ‘annoyed’,
‘concerned’, and ‘bothered’, all of which were reported
with high reliability (kappa  0.60–0.71); few individu-
als used distressing or ‘ashamed’. Interference with activ-
ities was associated with ability to travel, attending social
events and exercising (kappa0.60). CONCLUSIONS:
Using a 4-week recall period and with a 2-week interval
between interviews, we found that individuals are highly
reliable in reporting on coping strategies, psychological
impact, and the impact of bladder control on activities.
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Overactive bladder (OAB) is a chronic but treatable
problem among older adults. Epidemiological studies
suggest that OAB is widespread, largely untreated, and
healthcare systems may be incurring substantial costs.
OBJECTIVES: We examined older adults who received
medical services for OAB, the range of OAB services,
their cost to Medicare, and the dynamics of OAB treat-
ment. METHODS: Medicare claims covering 1994 and
1995 for a 5% sample of beneficiaries was analyzed to
derive treatment rates and profile OAB services and
costs. A Markov model was estimated to examine OAB
service utilization over time, and to compare costs among
patients receiving OAB services. RESULTS: Annually,
1.4 to 2.9% of Medicare elders receive medical services
for OAB; however, this group accounts for only 4 to 5%
of elderly with symptoms indicative of OAB. Average an-
nual Medicare costs for OAB services in 1995 was $298.
Although most patients were treated by physicians at
modest expense, most Medicare spending was for a small
percentage of patients who incurred expensive OAB care.
These high cost patients either underwent surgery for
OAB, or received OAB home health, or OAB care in a
skilled nursing facility. Annual costs of OAB services var-
ied with treatment setting. Patients treated in the physi-
cian’s office showed the lowest annual treatment cost.
CONCLUSIONS: Although OAB is widespread, most el-
ders avoid medical treatment. Yet, treatment in physician
offices is not expensive, particularly compared to the
costs of complications when OAB is left untreated. These
findings are important in view of the aging population
and the prevalence of OAB.
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OBJECTIVE: This study was conducted to determine the
influence of pharmaceutical care services on renal trans-
plant patients’ systolic and diastolic blood pressures.
METHODS: Renal transplant patients at the Medical
College of Georgia Renal Transplant Clinic were pro-
spectively randomized into an intervention or a control
group. Patients in the intervention group received phar-
maceutical care services at least once monthly which in-
cluded ongoing medication reviews, with emphasis on
preventing or resolving medication-related problems and
providing pharmacotherapy recommendations. Patients
in the control group received routine clinic services but
had no clinical pharmacist interaction. At each clinic
visit, all patients underwent a physical exam which in-
cluded blood pressure measurements. Analysis to detect
differences in baseline and quarterly systolic and diastolic
blood pressures between the groups was performed. RE-
SULTS: There were no differences in baseline systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
between the groups. Patients in the intervention group
(n  28) had a mean SBP/DBP change of 9 mm Hg/2
mm Hg, 13 mm Hg/8 mm Hg, 13 mm Hg/10 mm
Hg, and 6 mm Hg/6 mm Hg for the first through the
fourth quarters of the study, respectively. Patients in the
control group (n  23) had a mean SBP/DBP change of
2 mm Hg/1 mm Hg, 10 mm Hg/3 mm Hg, 11
mm Hg/1 mm Hg, and 12 mm Hg/5 mm Hg for the
first through the fourth quarters of the study, respec-
tively. Significant differences in change scores from base-
line for SBP and DBP between the intervention and con-
trol groups were observed at the second, third, and
fourth quarters of the study (P  0.01). CONCLUSION:
Patients who received a hypertension management pro-
gram which included pharmaceutical care services had
greater reductions in blood pressure than patients who
did not receive these services.
